
Organon & Co. — Investor Relations & Filings
Organon & Co. is a global healthcare company dedicated to improving the health of women. The company's portfolio is structured around three core pillars: Women's Health, Biosimilars, and Established Brands. The Women's Health division focuses on reproductive health, including contraception and fertility, as well as other conditions unique to women. The Biosimilars business aims to provide more accessible treatment options, particularly in oncology and immunology. The Established Brands unit manages a diverse range of therapies for conditions such as cardiovascular disease, respiratory illnesses, dermatology, and neurology. Organon's portfolio includes more than 70 medicines and devices, which are available in over 140 markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM SD | 2026-05-29 | English | |
| 10-Q - Organon & Co. (0001821825) (Filer) | 2026-05-04 | English | |
| 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-30 | English | |
| 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-27 | English | |
| 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | |
| 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47882447 | FORM SD | 2026-05-29 | English | ||
| 40904289 | 10-Q - Organon & Co. (0001821825) (Filer) | 2026-05-04 | English | ||
| 39076594 | 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-30 | English | ||
| 37390208 | 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-27 | English | ||
| 32899042 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899043 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899041 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899046 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899044 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899047 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899053 | 10-K - ORGANON & CO. (0001821825) (Filer) | 2026-02-24 | English | ||
| 32899049 | 8-K - ORGANON & CO. (0001821825) (Filer) | 2026-02-20 | English | ||
| 31899172 | 8-K Filing | 2026-02-12 | English | ||
| 13296055 | FORM 4/A | 2026-01-16 | English | ||
|
2025
1 filing
| |||||
| 13296058 | FORM 4 | 2025-11-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CAPRICOR THERAPEUTICS, INC.
A clinical-stage biotech developing cell and exosome-based …
|
CAPR | US | Manufacturing |
|
Cardiogeni Plc
A clinical-stage biotech developing regenerative medicines …
|
— | GB | Manufacturing |
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory and ant…
|
CRDL | CA | Manufacturing |
|
CAREGEN CO.,LTD.
Develops biomimetic peptides and growth factors for aesthet…
|
214370 | KR | Manufacturing |
|
Caribou Biosciences, Inc.
Clinical-stage biopharma developing genome-edited allogenei…
|
CRBU | US | Manufacturing |
|
Carisma Therapeutics Inc.
A clinical-stage biotech developing engineered macrophage-b…
|
CARM | US | Manufacturing |
|
Carna Biosciences, Inc.
Clinical-stage biopharma developing small molecule kinase i…
|
4572 | JP | Manufacturing |
|
CARsgen Therapeutics Holdings Limited
Clinical-stage biopharma focused on developing innovative C…
|
2171 | HK | Manufacturing |
|
Cartesian Therapeutics, Inc.
A clinical-stage company developing mRNA-engineered cell th…
|
RNAC | US | Manufacturing |
|
CASI Pharmaceuticals, Inc.
Biopharmaceutical firm developing therapeutics for organ tr…
|
CASI | US | Manufacturing |
Organon & Co. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31461/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31461 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31461 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31461 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31461}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Organon & Co. (id: 31461)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.